Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: Thrombosis recurrence
Conclusions This study suggest, that in primary APS, persistent negative aPL profile is not an indication to interrupt oral anticoagulant therapy. However, there is a subset of patients that remained asymptomatic. Other studies are necessary in order to elucidate this controversy.
Source: Autoimmunity Reviews - Category: Allergy & Immunology Source Type: research
More News: Allergy & Immunology | Antiphospholipid Syndrome | Hughes Syndrome | Hypertension | Ischemic Stroke | Lupus | Pulmonary Thromboembolism | Statistics | Stroke | Study | Thrombocytopenia | Thrombosis